These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt||2009-015758-39||Phase I/II, Multicenter, Single-Arm Clinical Trial of Panitumumab in Combination with Cisplatin, Fluourouracil and Docetaxel (DCF) in Locally Advanced or Metastatic Cancer of the Stomach and Gastro-oe...||2015-12-12||not-yet-due|
|Not reported||2010-022520-73||Phase II, open-label non-randomized trial to investigate the efficacy of Bevacizumab in combination with dose dense sequential chemotherapy in the neo-adjuvant setting for HER2 negative breast cancer ...||2015-12-17||due-trials|
|Not reported||2011-000879-14||A Phase II Trial of Pazopanib, in Relapsed and Refractory Small Cell Lung Cancer (SCLC).||2015-12-10||due-trials|
|Not reported||2011-002087-24||A phase II study of Temsirolimus in patients with advanced hormone - and chemotherapy - resistant prostate cancer.||2015-10-30||due-trials|
|Not reported||2012-000275-16||A pilot phase II trial of cabazitaxel in patients with metastatic NSCLC progressing after docetaxel-based treatment||2014-05-06||due-trials|
|Not reported||2012-002179-32||A Multicenter, Phase II, Single-Arm Clinical Trial of nab-Paclitaxel as salvage treatment for patients with Locally Advanced or Metastatic Adenocarcinomas of the Stomach and Gastro-esophageal junction||2015-12-03||due-trials|
|Ongoing||2014-001422-16||An open label, non-randomized, phase two trial in metastatic colorectal cancer (mCRC) with the combination of mFOLFIRI plus Aflibercept as first treatment: MINOAS trial||not-yet-due|
|Ongoing||2016-001335-12||A longitudinal study evaluating molecular changes associated with resistance to first and third (AZD9291) generation EGFR TKIs in patients with EGFR mutant NSCLC using "liquid biopsy"||not-yet-due|